Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Payables (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed Payables for 15 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • Quarterly Payables fell 8.6% to $5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2025, down 8.6% year-over-year, with the annual reading at $5.7 million for FY2025, 4.87% down from the prior year.
  • Payables hit $5.3 million in Q4 2025 for Mesa Laboratories, up from $5.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $7.9 million in Q1 2022 to a low of $4.0 million in Q2 2021.
  • Historically, Payables has averaged $5.9 million across 5 years, with a median of $5.7 million in 2024.
  • Biggest five-year swings in Payables: soared 140.98% in 2021 and later plummeted 37.84% in 2023.
  • Year by year, Payables stood at $7.8 million in 2021, then decreased by 19.66% to $6.3 million in 2022, then dropped by 27.58% to $4.6 million in 2023, then grew by 26.2% to $5.7 million in 2024, then dropped by 8.6% to $5.3 million in 2025.
  • Business Quant data shows Payables for MLAB at $5.3 million in Q4 2025, $5.1 million in Q3 2025, and $6.3 million in Q2 2025.